AML cells and KG1a cells with high ALDH2 expression all presented smaller changes in the proportion of Annexin V+ cells after Ara-C treatment, demonstrating enhanced resistance to Ara-C (Fig. 1H). The gene discussed is ANXA5; the disease is acute myeloid leukemia.